Simulations Plus to Present at Key Healthcare Investment Forums
Event summary
- Simulations Plus CEO Shawn O’Connor will participate in three investor conferences in February and March 2026.
- The conferences include the BTIG MedTech Conference (February 10, Utah), the TD Cowen Healthcare Conference (March 3, Boston), and the KeyBanc Healthcare Forum (March 18, virtual).
- The BTIG and TD Cowen conferences will feature both one-on-one meetings and fireside chats.
- Webcast links for the events will be posted on Simulations Plus’ investor relations website.
The big picture
Simulations Plus’ participation in these conferences underscores the company’s ongoing efforts to engage with the investment community and highlight its position as a leader in model-informed drug development. The conferences provide a platform to articulate the value proposition of AI-accelerated drug development, a sector attracting significant investment as biopharma companies seek to improve efficiency and reduce development timelines. These events also offer insight into management’s expectations for future growth and potential strategic initiatives.
What we're watching
- Growth Trajectory
- How the company frames its AI-acceleration strategy during these presentations will indicate the pace of adoption and potential revenue impact within the biopharma sector.
- Competitive Landscape
- The content of the fireside chats may reveal how Simulations Plus differentiates itself from competitors in the model-informed drug development space, particularly given the increasing number of entrants.
- Advisor Influence
- The involvement of BTIG, TD Cowen, and KeyBanc suggests a concerted effort to manage investor perception; tracking their post-conference commentary will be crucial.
Related topics